82926-64-5

Basic information

• Product Name: 9α-fluoro-3,11β,17α,21-tetrahydroxy-16β-methyl-1,3,5-pregnatriene-20-one 3-benzoate 17,21-dipropionate
• CAS NO: 82926-64-5
• Molecular Weight: 608.704
• Mol File: 82926-64-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 9α-fluoro-3,11β,17α,21-tetrahydroxy-16β-methyl-1,3,5-pregnatriene-20-one 3-benzoate 17,21-dipropionate(CAS DataBase Reference)
• NIST Chemistry Reference: 9α-fluoro-3,11β,17α,21-tetrahydroxy-16β-methyl-1,3,5-pregnatriene-20-one 3-benzoate 17,21-dipropionate(82926-64-5)
• EPA Substance Registry System: 9α-fluoro-3,11β,17α,21-tetrahydroxy-16β-methyl-1,3,5-pregnatriene-20-one 3-benzoate 17,21-dipropionate(82926-64-5)

Safety Data

• Hazardous Substances Data: 82926-64-5(Hazardous Substances Data)

Upstream product

• 5593-20-4 betamethasone dipropionate 
• 98-88-4 benzoyl chloride 

Downstream Products

• 72559-98-9 9α-fluoro-6,11β,17α,21-tetrahydroxy-16β-methyl-1,4,6-pregnatriene-3,20-dione 6-benzoate 17,21-dipropionate 

Relevant articles and documents

Synthesis and topical antiinflammatory potencies of a series of 6-keto- and Δ6-6-acyloxybetamethasone derivatives

6-Keto and Δ6-6-acyloxybetamethasone esters were synthesized, and tested for topical antiinflammatory potency using a modification of the Tonelli croton ear assay. The introduction of a 6-keto group generally led to retention of topical antiinflammatory potencies when compared to the corresponding 6-desoxycorticoids. In contrast, introduction of the Δ6-6-acyloxy moiety into betamethasone 17,21-dipropionate reduced antiinflammatory potency.